- Home
- HYMC vs SGMO Comparison
HYMC vs SGMO Comparison
Compare HYMC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYMC
- SGMO
- Stock Information
- Founded
- HYMC N/A
- SGMO 1995
- Country
- HYMC United States
- SGMO United States
- Employees
- HYMC N/A
- SGMO N/A
- Industry
- HYMC Precious Metals
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HYMC Basic Materials
- SGMO Health Care
- Exchange
- HYMC Nasdaq
- SGMO Nasdaq
- Market Cap
- HYMC 126.5M
- SGMO 122.8M
- IPO Year
- HYMC N/A
- SGMO 2000
- Fundamental
- Price
- HYMC $3.47
- SGMO $0.56
- Analyst Decision
- HYMC
- SGMO Buy
- Analyst Count
- HYMC 0
- SGMO 6
- Target Price
- HYMC N/A
- SGMO $4.50
- AVG Volume (30 Days)
- HYMC 538.8K
- SGMO 5.9M
- Earning Date
- HYMC 08-12-2025
- SGMO 08-12-2025
- Dividend Yield
- HYMC N/A
- SGMO N/A
- EPS Growth
- HYMC N/A
- SGMO N/A
- EPS
- HYMC N/A
- SGMO N/A
- Revenue
- HYMC N/A
- SGMO $63,756,000.00
- Revenue This Year
- HYMC N/A
- SGMO $1.29
- Revenue Next Year
- HYMC N/A
- SGMO $1.60
- P/E Ratio
- HYMC N/A
- SGMO N/A
- Revenue Growth
- HYMC N/A
- SGMO 239.92
- 52 Week Low
- HYMC $1.95
- SGMO $0.41
- 52 Week High
- HYMC $4.70
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- HYMC 48.07
- SGMO 54.90
- Support Level
- HYMC $3.22
- SGMO $0.50
- Resistance Level
- HYMC $4.11
- SGMO $0.70
- Average True Range (ATR)
- HYMC 0.21
- SGMO 0.05
- MACD
- HYMC -0.06
- SGMO 0.00
- Stochastic Oscillator
- HYMC 28.00
- SGMO 39.83
About HYMC Hycroft Mining Holding Corporation
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.